oxonc development lp
Pfizer To Conduct NSCLC Drug Trial In Asia
Pfizer Inc. will conduct a clinical trial of its crizotinib drug, marketed under the trademark Xalkori®, in four Asian countries.
Pfizer Inc. will conduct a clinical trial of its crizotinib drug, marketed under the trademark Xalkori®, in four Asian countries.